SillaJen, Inc. (215600.KQ)
KRW 2565.0
(0.79%)
KRW 2565.0
(0.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.36 Billion KRW | 17.18% |
| 2022 | -24.59 Billion KRW | -60.68% |
| 2021 | -15.3 Billion KRW | 68.0% |
| 2020 | -47.82 Billion KRW | 57.75% |
| 2019 | -113.19 Billion KRW | -101.29% |
| 2018 | -56.23 Billion KRW | 1.38% |
| 2017 | -57.02 Billion KRW | 22.98% |
| 2016 | -74.03 Billion KRW | -32.56% |
| 2015 | -55.85 Billion KRW | -2154.09% |
| 2014 | -2.47 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -5.06 Billion KRW | 15.02% |
| 2024 Q2 | -6.7 Billion KRW | -32.49% |
| 2023 Q3 | -5.33 Billion KRW | -1.23% |
| 2023 FY | -20.36 Billion KRW | 17.18% |
| 2023 Q4 | -5.95 Billion KRW | -11.63% |
| 2023 Q1 | -3.6 Billion KRW | 56.43% |
| 2023 Q2 | -5.27 Billion KRW | -46.35% |
| 2022 Q2 | -4.97 Billion KRW | 16.39% |
| 2022 FY | -24.59 Billion KRW | -60.68% |
| 2022 Q1 | -5.94 Billion KRW | 22.97% |
| 2022 Q4 | -8.26 Billion KRW | -36.23% |
| 2022 Q3 | -6.06 Billion KRW | -22.04% |
| 2021 Q2 | 1.61 Billion KRW | 133.48% |
| 2021 Q4 | -7.72 Billion KRW | -52.33% |
| 2021 FY | -15.3 Billion KRW | 68.0% |
| 2021 Q1 | -4.83 Billion KRW | -1.98% |
| 2021 Q3 | -5.06 Billion KRW | -413.05% |
| 2020 FY | -47.82 Billion KRW | 57.75% |
| 2020 Q4 | -4.74 Billion KRW | 67.47% |
| 2020 Q3 | -14.57 Billion KRW | 18.76% |
| 2020 Q2 | -17.94 Billion KRW | -69.89% |
| 2020 Q1 | -10.56 Billion KRW | 9.45% |
| 2019 Q3 | -15.53 Billion KRW | 78.01% |
| 2019 Q1 | -15.33 Billion KRW | -34.65% |
| 2019 FY | -113.19 Billion KRW | -101.29% |
| 2019 Q4 | -11.66 Billion KRW | 24.93% |
| 2019 Q2 | -70.65 Billion KRW | -360.62% |
| 2018 Q2 | -13.47 Billion KRW | 4.49% |
| 2018 Q4 | -11.39 Billion KRW | 33.98% |
| 2018 Q3 | -17.25 Billion KRW | -28.02% |
| 2018 FY | -56.23 Billion KRW | 1.38% |
| 2018 Q1 | -14.11 Billion KRW | 15.65% |
| 2017 Q2 | -18.93 Billion KRW | -61.64% |
| 2017 FY | -57.02 Billion KRW | 22.98% |
| 2017 Q1 | -11.71 Billion KRW | 70.49% |
| 2017 Q4 | -16.73 Billion KRW | -73.66% |
| 2017 Q3 | -9.63 Billion KRW | 49.13% |
| 2016 Q4 | -39.7 Billion KRW | -173.81% |
| 2016 Q2 | -11.17 Billion KRW | -29.02% |
| 2016 Q1 | -8.66 Billion KRW | 50.97% |
| 2016 FY | -74.03 Billion KRW | -32.56% |
| 2016 Q3 | -14.49 Billion KRW | -29.75% |
| 2015 Q3 | -9.88 Billion KRW | 36.19% |
| 2015 Q4 | -17.66 Billion KRW | -78.74% |
| 2015 Q2 | -15.49 Billion KRW | -20.9% |
| 2015 Q1 | -12.81 Billion KRW | -235.57% |
| 2015 FY | -55.85 Billion KRW | -2154.09% |
| 2014 FY | -2.47 Billion KRW | 0.0% |
| 2014 Q2 | -739.07 Million KRW | 79.22% |
| 2014 Q3 | -7.63 Billion KRW | -932.69% |
| 2014 Q4 | 9.45 Billion KRW | 223.83% |
| 2014 Q1 | -3.55 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HLB Co., Ltd. | -189.07 Billion KRW | 89.227% |
| iNtRON Biotechnology, Inc. | -9.69 Billion KRW | -110.092% |
| BINEX Co., Ltd. | 4.67 Billion KRW | 536.102% |
| Bioneer Corporation | -10.58 Billion KRW | -92.398% |
| Anterogen.Co.,Ltd. | -2.84 Billion KRW | -617.012% |
| MEDIPOST Co., Ltd. | 5.83 Billion KRW | 448.788% |
| CrystalGenomics, Inc. | -48.92 Billion KRW | 58.365% |
| Helixmith Co., Ltd | -64.08 Billion KRW | 68.217% |
| Chabiotech Co.,Ltd. | -8.43 Billion KRW | -141.592% |
| Medy-Tox Inc. | 9.75 Billion KRW | 308.806% |
| Peptron, Inc. | -15.92 Billion KRW | -27.932% |
| Amicogen, Inc. | -23.28 Billion KRW | 12.537% |
| Genexine, Inc. | -66.87 Billion KRW | 69.541% |
| HLB Therapeutics Co.,Ltd. | -2.3 Billion KRW | -784.789% |
| LegoChem Biosciences, Inc. | -73.7 Billion KRW | 72.363% |
| ALTEOGEN Inc. | -3.37 Billion KRW | -504.112% |
| PharmaResearch Co., Ltd. | 76.55 Billion KRW | 126.609% |
| JETEMA, Co., Ltd. | 13.96 Billion KRW | 245.85% |
| OliX Pharmaceuticals,Inc | -19.1 Billion KRW | -6.636% |
| Genomictree Inc. | -8.75 Billion KRW | -132.631% |
| MedPacto, Inc. | -35.32 Billion KRW | 42.337% |
| D&D Pharmatech | 3.93 Billion KRW | 617.8% |
| EASY BIO,Inc. | 15.54 Billion KRW | 231.044% |
| GI Innovation, Inc. | -55.49 Billion KRW | 63.296% |